Latest News

Use of testosterone does not lead to abnormal hematocrit levels
Use of testosterone does not lead to abnormal hematocrit levels

November 27th 2023

"The findings from this study represent very important reassurance regarding the safety of testosterone as masculinizing treatment," says Joshua Safer, MD, FACP, FACE.

Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Urology in the Lab: Researchers link EBV to multiple sclerosis

November 27th 2023

Female doctor working on a tablet | Image Credit: © NINENII - stock.adobe.com
2024 Medicare final rule: Here comes code G2211

November 25th 2023

NCCN awards funding to 4 advanced prostate cancer research projects
NCCN awards funding to 4 advanced prostate cancer research projects

November 24th 2023

Study links PARP inhibitors to increased risk of hematologic toxicity in mCRPC patients
Study links PARP inhibitors to increased risk of hematologic toxicity in mCRPC patients

November 23rd 2023

Latest Videos

Latest News

© 2023 MJH Life Sciences

All rights reserved.